Potential Application of Liposomal Nanodevices for Non-Cancer Diseases: An Update on Design, Characterization and Biopharmaceutical Evaluation Publisher Pubmed



Bayat F¹ ; Hosseinpourmoghadam R¹ ; Mehryab F¹ ; Fatahi Y^{2, 3} ; Shakeri N¹ ; Dinarvand R² ; Ten Hagen TLM⁴ ; Haeri A^{1, 5} Show Affiliations
Source: Advances in Colloid and Interface Science Published:2020

Abstract

Liposomes, lipid-based vesicular systems, have attracted major interest as a means to improve drug delivery to various organs and tissues in the human body. Recent literature highlights the benefits of liposomes for use as drug delivery systems, including encapsulating of both hydrophobic and hydrophilic cargos, passive and active targeting, enhanced drug bioavailability and therapeutic effects, reduced systemic side effects, improved cargo penetration into the target tissue and triggered contents release. Pioneering work of liposomes researchers led to introduction of long-circulating, ligand-targeted and triggered release liposomes, as well as, liposomes containing nucleic acids and vesicles containing combination of cargos. Altogether, these findings have led to widespread application of liposomes in a plethora of areas from cancer to conditions such as cardiovascular, neurologic, respiratory, skin, autoimmune and eye disorders. There are numerous review articles on the application of liposomes in treatment of cancer, which seems the primary focus, whereas other diseases also benefit from liposome-mediated treatments. Therefore, this article provides an illustrated detailed overview of liposomal formulations, in vitro characterization and their applications in different disorders other than cancer. Challenges and future directions, which must be considered to obtain the most benefit from applications of liposomes in these disorders, are discussed. © 2020 Elsevier B.V.